Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

Market Cap	23.84B -0.2%
Revenue (ttm)	8.59B -10.1%
Net Income	266.40M -76.2%
EPS	0.18 -76.6%
Shares Out	1.49B
PE Ratio	88.89
Forward PE	15.53
Dividend	0.25 (1.56%)
Ex-Dividend Date	Jul 10, 2025

Volume	33,143,729
Average Volume	26,399,055
Open	16.01
Previous Close	16.00
Day's Range	15.88 - 16.60
52-Week Range	14.10 - 27.97
Beta	0.17
RSI	53.68
Earnings Date	Apr 30, 2026

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade serv...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 9,065
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600521

Financial Performance

In 2025, SHA:600521's revenue was 8.59 billion, a decrease of -10.06% compared to the previous year's 9.55 billion. Earnings were 266.40 million, a decrease of -76.19%.